New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 4, 2006, Pages 333-341

  Ubara, Yoshifumi ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Angiogenesis; Arteriogenesis; Autosomal dominant polycystic kidney disease; Polycystic liver; Transcatheter arterial embolization; Vascular endothelial growth factor

Indexed keywords

ADULT; ANGIOGENESIS; CASE REPORT; CHEMOEMBOLIZATION; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEPATOMEGALY; HUMAN; KIDNEY HYPERTROPHY; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; LIVER CYST; MALE; NUTRITIONAL STATUS; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL ARTERY; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

CYSTS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; JAPAN; KIDNEY; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; NUTRITIONAL STATUS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 33746628908     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00386.x     Document Type: Review

References (35)

1. Hughes J, Ward CJ, Peral B et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10:151-60.
2. Qian Q, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 1996;87:979-87.
3. Mochizuki T, Wu G, Hayashi T et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339-42.
4. Hayashi T, Mochizuki T, Reynolds DM, Wu G, Somlo S. Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2). Genetics 1997;44:131-6.
5. Grantham JJ. The etiology, pathogenesis and treatment of autosomal dominant polycystic kidney disease: recent study. Am J Kidney Dis 1996;28:788-803.
6. Griffin MD, Torres VE, Grande JP, Kumar R. Vascular expression of polycystin. J Am Soc Nephrol 1997;8:616-26.
7. Torres VE, Cai Y, Chen X et al. Vascular expression of polycystin-2. J Am Soc Nephrol 2001;12:1-9.
8. Segura TW, King BF, Towsey SG et al. Chronic pain and its medical and surgical management in renal cystic diseases. In: Watson ML, Torres VE, eds. Polycystic Kidney Disease. Oxford: Oxford University Press, 1996;462-80.
9. Bennett WM, Elzinga L, Golper TA, Barry JM. Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol 1987;137:620-2.
10. Uemasu J, Fujiwara M, Munemura C, Tokumoto A, Kawasaki H. Effects of topical instillation of monocycline hydrochloride on cyst size and renal function in polycystic kidney disease. Clin Nephrol 1993;39:140-4.
11. Elzinga LW, Barry JM, Bennett WM. Surgery in the management of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992;19:89-92.
12. Elzinga LW, Barry JM, Torres VE et al. Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992;2:219-26.
13. Elashry OM, Nakada SY, Wolf. JS, McDougall EM, Clayman RV. Laparoscopy for adult polycystic kidney disease: a promising alternative. Am J Kidney Dis 1996;27:224-33.
14. Dunn MD, Portis AJ, Elbahnsy AM et al. Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000;35:720-5.
15. Mandelsson DC, Harding ME, Cardella CJ, Cook GT, Uldall PR. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation. Clin Nephrol 1988;30:315-19.
16. Cassuto-Viguier E, Quintens H, Cbevallier D et al. Transplantation and nephrectomy in autosomal dominant polycystic disease. Clin Nephrol 1991;36:105-6.
17. Milutinovic J. Massive growth of kidneys in patients with autosomal dominant polycystic kidney disease treated with chronic hemodialysis. Am J Kidney Dis 1989;5:365-8.
18. Ubara Y, Katori H, Tagami T et al. Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. Am J Kidney Dis 1999;34:926-31.
19. Ubara Y, Tetsuo T, Naoki S et al. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis 2002;39:571-9.
20. Harley JD, Shen FH, Carter SJ. Transcatheter infarction of a polycystic kidney for control of recurrent hemorrhage. AJR Am J Roentgenol 1980;134:818-20.
21. Bello-Reuss E, Holubec K, Rajaraman S. Angiogenesis in autosomal-dominant polycystic kidney disease. Kidney Int 2001;60:37-45.
22. Simon M, Grone HJ, Johren J et al. Expression of vascular endothelial growth factor and it receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995;268:F240-50.
23. Brooks PC, Silletti S, Von Schalcha TL, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase-2 fragment with integrin binding activity. Cell 1998;92:391-400.
24. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999;56:794-814.
25. Senger SR, Galli SJ, Dvorak AM et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitis fluid. Science 1983;219:983-5.
26. 3. Cell 1996;85:683-93.
27. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kita Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 1994;267:H1948-54.
28. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
29. Nakai S, Shinzato T, Nagura Y et al. An overview of regular dialysis treatment in Japan (as of December 31, 2001). Ther Apher Dial 2004;8:3-32.
30. Que F, Nagorney DM, Gross JB Jr, Torres VE. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 1995;108:487-94.
31. Soravia C, Mentha G, Giostra E, Morel P, Rohner A. Surgery for adult polycystic liver disease. Surgery 1995;117:272-5.
32. Lang H, Woellwarth JV, Oldhafer KJ et al. Liver transplantation in patients with polycystic liver disease. Transplant Proc 1997;29:2832-3.
33. Swenson K, Seu P, Kinkhabwala M et al. Liver transplantation for adult polycystic liver disease. Hepatology 1998;28:412-15.
34. Jeyarajan DR, Gonwa TA, Testa G et al. Liver and kidney transplantation for polycystic disease. Transplantation 1998;66:529-32.
35. Ubara Y, Takei R, Hoshino J et al. Intravascular embolization therapy in a patient with an enlarged polycystic liver. Am J Kidney Dis April 2004;43:733-8.